Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cambrex | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Cambrex

Revenues slipped due to several factors

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex 2Q10

2Q Revenues: $58.2 million (-2%)

2Q Earnings: $4.8 million (-13%)

YTD Revenues: $114.3 million (-5%)

YTD Earnings: $6.4 million (-37%)

Comments: The drop in revenues was blamed on reduced demand for some large products, a supply chain disruption at a customer’s facility, lower pricing on generic APIs, and a renegotiated contract extension for drug delivery products, resulting in lower pricing. Increased sales volume for controlled substances and generic APIs helped offset some of the drop.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics